TD Cowen Maintains Buy Rating on NeoGenomics
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Shanghai Composite Opens 1.3% Lower
M impact | EQUITY | Oct 30, 2026, 01:32 AM UTC
Doctor Care Anywhere Reports Q3 2026 Revenue of £11.3M
M impact | EQUITY | Oct 30, 2026, 01:28 AM UTC
China 5G Communications Index Set to Open Down More Than 5%
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC
Daewoo E&C Signs Amended 274.89 Billion Won Housing Contract
Daewoo E&C signed an amended 274.89 billion won contract for Changwon housing redevelopment.
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC
Calmer Co International Posts Q1 FY27 Revenue of A$2.44 Million
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC
China’s CSI Index Set to Open Down 1.4%
M impact | EQUITY | Oct 30, 2026, 01:27 AM UTC